(Q68198214)
Statements
Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma (English)
Lucarotti ME
Habib NA
Kelly SB
Rothnie ND
Nelson O
Lindholm L
Cooper MJ
Wood CB
1 February 1991